| __timestamp | ADMA Biologics, Inc. | Alkermes plc |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 7753000 |
| Thursday, January 1, 2015 | 7015946 | 4019000 |
| Friday, January 1, 2016 | 7688238 | 2301000 |
| Sunday, January 1, 2017 | 6229587 | 7232000 |
| Monday, January 1, 2018 | 3926120 | 68895000 |
| Tuesday, January 1, 2019 | 2343848 | 52816000 |
| Wednesday, January 1, 2020 | 5907013 | 1946000 |
| Friday, January 1, 2021 | 3646060 | 1020000 |
| Saturday, January 1, 2022 | 3613764 | 393842000 |
| Sunday, January 1, 2023 | 3300000 | 270806000 |
| Monday, January 1, 2024 | 245326000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal for innovation and growth. Over the past decade, Alkermes plc and ADMA Biologics, Inc. have demonstrated contrasting strategies in their R&D expenditures. From 2014 to 2023, Alkermes plc has shown a remarkable increase in R&D spending, peaking in 2022 with a staggering 393 million USD, a 50-fold increase from its 2014 investment. In contrast, ADMA Biologics, Inc. has maintained a more conservative approach, with its highest expenditure in 2014 at approximately 9.5 million USD, gradually decreasing to 3.3 million USD by 2023. This divergence highlights Alkermes' aggressive pursuit of innovation, while ADMA Biologics focuses on steady, sustainable growth. As the biotech industry continues to expand, these investment strategies will play a crucial role in shaping the future of healthcare solutions.
Comparing Innovation Spending: Eli Lilly and Company and ADMA Biologics, Inc.
Eli Lilly and Company or Alkermes plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for BeiGene, Ltd. and Alkermes plc
Research and Development Investment: Summit Therapeutics Inc. vs Alkermes plc
R&D Insights: How Summit Therapeutics Inc. and ADMA Biologics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and Alkermes plc
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Axsome Therapeutics, Inc. or ADMA Biologics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How ADMA Biologics, Inc. and MiMedx Group, Inc. Allocate Funds